Demyelination in multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS) involves purinergic receptors signaling, since the nucleotides released in large quantities under inflammatory conditions and following cell death are important mediators in demyelinating diseases. This evidence concerns the gene P2RX2 and amyotrophic lateral sclerosis.